34 related articles for article (PubMed ID: 33589435)
1. Gene Expression Profiling and PRAME Status Versus Tumor-Node-Metastasis Staging for Prognostication in Uveal Melanoma.
Cai L; Paez-Escamilla M; Walter SD; Tarlan B; Decatur CL; Perez BM; Harbour JW
Am J Ophthalmol; 2018 Nov; 195():154-160. PubMed ID: 30092184
[TBL] [Abstract][Full Text] [Related]
2. Validation of the Prognostic Usefulness of the Gene Expression Profiling Test in Patients with Uveal Melanoma.
Miguez S; Lee RY; Chan AX; Demkowicz PC; Jones BSCL; Long CP; Abramson DH; Bosenberg M; Sznol M; Kluger H; Goldbaum MH; Francis JH; Pointdujour-Lim R; Bakhoum MF
Ophthalmology; 2023 Jun; 130(6):598-607. PubMed ID: 36739981
[TBL] [Abstract][Full Text] [Related]
3. 31-Gene Expression Profile Testing in Cutaneous Melanoma and Survival Outcomes in a Population-Based Analysis: A SEER Collaboration.
Bailey CN; Martin BJ; Petkov VI; Schussler NC; Stevens JL; Bentler S; Cress RD; Doherty JA; Durbin EB; Gomez SL; Gonsalves L; Hernandez BY; Liu L; Morawski BM; Schymura MJ; Schwartz SM; Ward KC; Wiggins C; Wu XC; Goldberg MS; Siegel JJ; Cook RW; Covington KR; Kurley SJ
JCO Precis Oncol; 2023 Jun; 7():e2300044. PubMed ID: 37384864
[TBL] [Abstract][Full Text] [Related]
4. The 31-Gene Expression Profile Test Outperforms AJCC in Stratifying Risk of Recurrence in Patients with Stage I Cutaneous Melanoma.
Podlipnik S; Martin BJ; Morgan-Linnell SK; Bailey CN; Siegel JJ; Petkov VI; Puig S
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254778
[TBL] [Abstract][Full Text] [Related]
5. Prognostic implications of tenascin C in peripheral blood and primary tumours at the time of uveal melanoma diagnosis.
Herrspiegel C; Plastino F; André H; Stålhammar G
Can J Ophthalmol; 2024 Jan; ():. PubMed ID: 38219791
[TBL] [Abstract][Full Text] [Related]
6. Gene Expression Profile Class Change in a Case of Aggressive, Recurrent Melanoma.
Aye J; Gold A; Rodriguez B; Murray T
J Vitreoretin Dis; 2024; 8(1):93-96. PubMed ID: 38223774
[No Abstract] [Full Text] [Related]
7. Risk prediction in cutaneous melanoma patients from their clinico-pathological features: superiority of clinical data over gene expression data.
Arora C; Kaur D; Lathwal A; Raghava GPS
Heliyon; 2020 Aug; 6(8):e04811. PubMed ID: 32913910
[TBL] [Abstract][Full Text] [Related]
8. Impact of staging on survival outcomes: a nationwide real-world cohort study of metastatic uveal melanoma.
Rantala ES; Kivelä TT; Hernberg MM
Melanoma Res; 2021 Jun; 31(3):224-231. PubMed ID: 33595243
[TBL] [Abstract][Full Text] [Related]
9. Management of Uveal Melanoma: Updated Cancer Care Alberta Clinical Practice Guideline.
Weis E; Surgeoner B; Salopek TG; Cheng T; Hyrcza M; Kostaras X; Larocque M; McKinnon G; McWhae J; Menon G; Monzon J; Murtha AD; Walker J; Temple-Oberle C
Curr Oncol; 2023 Dec; 31(1):24-41. PubMed ID: 38275828
[TBL] [Abstract][Full Text] [Related]
10. Improved Prognostic Precision in Uveal Melanoma through a Combined Score of Clinical Stage and Molecular Prognostication.
Stacey AW; Dedania VS; Materin M; Demirci H
Ocul Oncol Pathol; 2022 Feb; 8(1):35-41. PubMed ID: 35356606
[TBL] [Abstract][Full Text] [Related]
11. Metastatic Risk Factors Associated with Class 1A Uveal Melanoma Patients.
Ballhausen A; Urias E; Gruschkus SK; Williams M; Glover MS; Qin Y; Gombos DS; Patel SP
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34209210
[TBL] [Abstract][Full Text] [Related]
12. Gene Expression Profiling Prognostication of Posterior Uveal Melanoma: Does Size Matter?
Binkley EM; Bena JF; Davanzo JM; Hinz C; Boldt HC; Singh AD
Ophthalmol Retina; 2020 Jun; 4(6):620-629. PubMed ID: 32081600
[TBL] [Abstract][Full Text] [Related]
13. Independent Prognostic Significance of Gene Expression Profile Class and Largest Basal Diameter of Posterior Uveal Melanomas.
Corrêa ZM; Augsburger JJ
Am J Ophthalmol; 2016 Feb; 162():20-27.e1. PubMed ID: 26596399
[TBL] [Abstract][Full Text] [Related]
14. Association between traditional clinical high-risk features and gene expression profile classification in uveal melanoma.
Nguyen BT; Kim RS; Bretana ME; Kegley E; Schefler AC
Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):421-427. PubMed ID: 29185101
[TBL] [Abstract][Full Text] [Related]
15. Prognostication of uveal melanoma is simple and highly predictive using The Cancer Genome Atlas (TCGA) classification: A review.
Shields CL; Dalvin LA; Vichitvejpaisal P; Mazloumi M; Ganguly A; Shields JA
Indian J Ophthalmol; 2019 Dec; 67(12):1959-1963. PubMed ID: 31755428
[TBL] [Abstract][Full Text] [Related]
16. Variability of Bad Prognosis in Uveal Melanoma.
Shao YF; Echegaray JJ; Singh N; Singh AD
Ophthalmol Retina; 2019 Feb; 3(2):186-193. PubMed ID: 31014770
[TBL] [Abstract][Full Text] [Related]
17. Optimising prediction of early metastasis-free survival in uveal melanoma using a four-category model incorporating gene expression profile and tumour size.
Roelofs KA; Grewal P; Lapere S; Larocque M; Murtha A; Weis E
Br J Ophthalmol; 2022 May; 106(5):724-730. PubMed ID: 33589435
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
